Anagenics Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 9.23 million compared to AUD 5.82 million a year ago. Net loss was AUD 3.65 million compared to AUD 3.39 million a year ago.

Basic loss per share from continuing operations was AUD 0.0174 compared to AUD 0.0269 a year ago. Diluted loss per share from continuing operations was AUD 0.0174 compared to AUD 0.0269 a year ago. Basic loss per share was AUD 0.0174 compared to AUD 0.024 a year ago.

Diluted loss per share was AUD 0.0174 compared to AUD 0.024 a year ago.